This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Encompass Health (EHC) Continues to Bolster Presence in Ohio
by Zacks Equity Research
Encompass Health (EHC) continues to expand in Ohio via inauguration of the inpatient rehabilitation hospital in order to offer improved health services in the state.
Encompass Health (EHC) to Build Rehabilitation Hub in Illinois
by Zacks Equity Research
Encompass Health (EHC) to construct an inpatient rehabilitation hospital with a capacity of 40 in Shiloh Illinois, which will be run as a joint venture with BJC HealthCare.
Encompass Health (EHC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 4.00% and -0.35%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Encompass Health (EHC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health Offers Senior Unsecured Notes Worth $400M
by Zacks Equity Research
Encompass Health (EHC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Encompass Health (EHC) Down 10.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health Forms JV to Efficiently Serve South Carolina
by Zacks Equity Research
Encompass Health (EHC) and MUSC Health intend to offer improved healthcare services in South Carolina through a joint venture.
Encompass Health's Buyout Spree on Track, PPE Costs High
by Zacks Equity Research
Encompass Health (EHC) continues to benefit from buyouts and cash generating abilities. However, increased PPE utilization is worrisome.
Encompass Health's (EHC) Expansion Plans Continue in Florida
by Zacks Equity Research
Encompass Health (EHC) continues to expand in Florida via hospitals in order to offer improved health services in the state.
Universal Health (UHS) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings reflect lower expenses, partially offset by reduced patient volumes.
Encompass Health (EHC) Lags Q2 Earnings Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of -20.51% and 1.13%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Encompass Health (EHC)
by Zacks Equity Research
Encompass Health (EHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Encompass Health (EHC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health Continues to Strengthen Presence in Florida
by Zacks Equity Research
Encompass Health (EHC) intends to offer improved health outcomes through plans to construct a new hospital in Florida, where it already boasts of a strong base.
Encompass Health Tie-Up to Improve Healthcare in Knoxville
by Zacks Equity Research
Encompass Health (EHC) and Covenant Health intend to offer improved healthcare services in Knoxville through a joint venture.
Healthcare for Silver Years to Aid Encompass Health (EHC)
by Zacks Equity Research
Encompass Health's (EHC) inpatient rehabilitation and home hospice businesses are poised to grow on the back of aging population.
Encompass Health to Build Rehabilitation Hospital in Illinois
by Zacks Equity Research
Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.
DGX vs. EHC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DGX vs. EHC: Which Stock Is the Better Value Option?
Encompass Health (EHC) Up 7.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Q1 Earnings Match Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 0.00% and -1.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Powerful Proof Anyone Can Invest for an Early Retirement - March 26, 2020
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
Signs That Your Trading Will Ruin Your Retirement - March 19, 2020
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
Want To Retire Early? Learn the Intelligent Investing Secret - March 18, 2020
by Zacks Equity Research
Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
Why Is Encompass Health (EHC) Down 3.2% Since Last Earnings Report?
by Zacks Equity Research
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of -2.30% and -0.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?